Cellular mechanisms and role of endothelin-1-induced calcium oscillations in pulmonary arterial myocytes

American Journal of Physiology - Lung Cellular and Molecular Physiology

Volumn 275, Issue 2 19-2, 1998, Pages

  Hyvelin, Jean Marc ^a   Guibert, Christelle ^a   Marthan, Roger ^a   Savineau, Jean Pierre ^a  

^a UNIVERSITÉ DE BORDEAUX   (France)

Author keywords

Calcium activated chloride current; Cytosolic calcium concentration measurement; Niflumic acid; Patch clamp; Vascular smooth muscle

Indexed keywords

CALCIUM ION; ENDOTHELIN 1; ENDOTHELIN A RECEPTOR; ENDOTHELIN B RECEPTOR; ENDOTHELIN RECEPTOR ANTAGONIST; INOSITOL TRISPHOSPHATE; NEOMYCIN; NIFEDIPINE; NIFLUMIC ACID; RUTHENIUM RED; THAPSIGARGIN;

ANIMAL CELL; ARTERY MUSCLE; ARTICLE; CALCIUM CELL LEVEL; CALCIUM CURRENT; CALCIUM TRANSPORT; CELL MEMBRANE DEPOLARIZATION; CONTROLLED STUDY; LUNG VASCULAR RESISTANCE; MEDIATOR RELEASE; MUSCLE ISOMETRIC CONTRACTION; NONHUMAN; PATCH CLAMP; PRIORITY JOURNAL; PULMONARY ARTERY; RAT; RECEPTOR BLOCKING; REGULATORY MECHANISM; SIGNAL TRANSDUCTION;

EID: 0031844497     PISSN: 10400605     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajplung.1998.275.2.l269     Document Type: Article

References (46)

1. Archer, S. L., J. M. C. Huang, H. L. Reeve, V. Hampl, S. Tolarova, Z. Michelakis, and E. K. Wier. Differential distribution of electrophysiologically distinct myocytes in conduit and resistance arteries determines their response to nitric oxide and hypoxia. Circ. Res. 78: 431-442, 1996.
2. + currents in arterial myocytes. Biochem. Biophys. Res. Commun. 227: 168-175, 1996.
3. Barnes, P. J., and S. F. Liu. Regulation of pulmonary vascular tone. Pharmacol. Rev. 47: 87-131, 1995.
4. Chen, C., and P. K. Wagoner. Endothelin induces a nonselective cation current in vascular smooth muscle cells. Circ. Res. 69: 447-454, 1991.
5. Clapp, L. H., and A. M. Gurney. Outward currents in rabbit pulmonary artery cells dissociated with a new technique. Exp. Physiol. 76: 677-693, 1991.
6. Cockcroft, S., and B. D. Gomperts. Role of guanine nucleotide binding protein in the activation of polyphosphoinositide phosphodiesterase. Nature 314: 534-536, 1985.
7. Dzau, V. J. Cell biology and genetics of angiotensin in cardiovascular disease. J. Hypertens. Suppl. 12: S3-S10, 1994.
8. Franco-Obregon, A., and J. Lopez-Barneo. Differential oxygen sensitivity of calcium channels in rabbit smooth muscle cells of conduit and resistance pulmonary arteries. J. Physiol. (Lond.) 491: 511-518, 1996.
9. Fukuroda, T., M. Kobayashi, S. Ozaki, M. Yano, T. Miyauchi, M. Onizuka, Y. Sugishita, K. Goto, and M. Nishikibe. Endothelin receptor subtypes in human versus rabbit pulmonary arteries. J. Appl. Physiol. 76: 1976-1982, 1994.
10. Gardner, J. P., G. Tokudome, H. Tomonari, E. Maher, D. Hollander, and A. Aviv. Endothelin-induced calcium responses in human vascular smooth muscle cells. Am. J. Physiol. 262 (Cell Physiol. 31): C148-C155, 1992.
11. Giaid, A., M. Yanagisawa, D. Langleben, R. P. Michel, R. Levy, H. Shennib, S. Kimura, T. Masaki, W. P. Duguid, and D. J. Stewart. Expression of endothelin-1 in the lungs of patients with pulmonary hypertension. N. Engl. J. Med. 328: 1732-1739, 1993.
12. 2+ pump blockers: thapsigargin and cyclopiazonic acid. Pflügers Arch. 429: 617-624, 1995.
13. 2+ channel in vascular smooth muscle. Proc. Natl. Acad. Sci. USA 86: 3915-3918, 1989.
14. 2+ indicators with greatly improved fluorescence properties. J. Biol. Chem. 260: 3440-3450, 1985.
15. 2+-oscillations in vascular myocytes from the rat pulmonary artery. Am. J. Physiol. 270 (Lung Cell. Mol. Physiol. 14): L637-L642, 1996.
16. 2+ concentration in rat pulmonary artery myocytes. Am. J. Physiol. 271 (Lung Cell. Mol. Physiol. 15): L450-L458, 1996.
17. Hamill, O. P., A. Marty, E. Neher, B. Sakmann, and F. J. Sigworth. Improved patch-clamp techniques for high-resolution current recording from cells and cell-free membrane patches. Pflügers Arch. 391: 85-100, 1981.
18. Higashi, T., T. Ishizaki, K. Shigemori, T. Nakai, S. Miyabo, T. Inui, and T. Yamamura. Pharmacological heterogeneity of constrictions mediated by endothelin receptors in rat pulmonary arteries. Am. J. Physiol. 272 (Lung Cell. Mol. Physiol. 16): L287-L293, 1997.
19. Ihara, M., K. Noguchi, T. Saeki, T. Fukuroda, S. Tsuchida, S. Kimura, T. Fukami, K. Ishikawa, M. Nishikibe, and M. Yano. Biological profiles of highly potent novel endothelin antagonists selective for the ETA receptor. Life Sci. 50: 247-255, 1992.
20. 2+ dependence of inositol 1,4,5-trisphosphate-induced Ca release in smooth muscle cells of the guinea pig taenia caeci. J. Gen. Physiol. 95: 1103-1122, 1990.
21. Ishikawa, K., M. Ihara, K. Noguchi, T. Mase, N. Mino, T. Saeki, T. Fukuroda, T. Fukami, S. Ozaki, T. Nagase, M. Nishikibe, and M. Yano. Biochemical and pharmacological profile of a potent and selective endothelin B-receptor antagonist, BQ-788. Proc. Natl. Acad. Sci. USA 91: 4892-4896, 1994.
22. 2+ oscillations of porcine tracheal smooth muscle. Am. J. Physiol. 272 (Lung Cell. Mol. Physiol. 16): L659-L664, 1997.
23. Kasuya, Y., Y. Takuwa, M. Yanagisawa, S. Kimura, K. Goto, and T. Masaki. Endothelin-1 induces vasoconstriction through two functionally distinct pathways in porcine coronary artery: contribution of phosphoinositide turnover. Biochem. Biophys. Res. Commun. 161: 1049-1055, 1989.
24. Kasuya, Y., Y. Takuwa, M. Yanagisawa, T. Masaki, and K. Goto. A pertussis toxin-sensitive mechanism of endothelin action in porcine coronary artery smooth muscle. Br. J. Pharmacol. 107: 456-462, 1992.
25. Kiely, D. G., R. I. Cargill, and B. J. Lipworth. Angiotensin II receptor blockade and effects on pulmonary hemodynamics and hypoxic pulmonary vasoconstriction in humans. Chest 110: 698-703, 1996.
26. Klockner, U., and G. Isenberg. Endothelin depolarizes myocytes from porcine coronary and human mesenteric arteries through a Ca-activated chloride current. Pflügers Arch. 418: 168-175, 1991.
27. - conductance in smooth muscle. Am. J. Physiol. 271 (Cell Physiol. 40): C435-C454, 1996.
28. Marrero, M. B., W. G. Paxton, B. Schieffer, B. N. Ling, and K. E. Bernstein. Angiotensin II signalling events mediated by tyrosine phosphorylation. Cell Signal. 8: 21-26, 1996.
29. Marsden, P. A., N. R. Danthuluri, B. M. Brenner, B. J. Ballermann, and T. A. Brock. Endothelin action on vascular smooth muscle involves inositol trisphosphate and calcium mobilization. Biochem. Biophys. Res. Commun. 158: 86-93, 1989.
30. McMillan, M., B. Chernow, and B. L. Roth. Phorbol esters inhibit alpha 1-adrenergic receptor-stimulated phosphoinositide hydrolysis and contraction in rat aorta: evidence for a link between vascular contraction and phosphoinositide turnover. Biochem. Biophys. Res. Commun. 134: 970-974, 1986.
31. + channels and depolarizes smooth muscle cells of porcine coronary artery. Circ. Res. 70: 612-616, 1992.
32. 2+ influx. J. Mol. Cell. Cardiol. 28: 707-722, 1996.
33. Pollock, D. M., T. L. Keith, and R. F. Highsmith. Endothelin receptors and calcium signaling. FASEB J. 9: 1196-1204, 1995.
34. Salter, K. J., and R. Z. Kozlowski. Endothelin receptor coupling to potassium and chloride channels in isolated rat pulmonary arterial myocytes. J. Pharmacol. Exp. Ther. 279: 1053-1062, 1996.
35. Savineau, J. P., R. Marthan, and H. Crevel. Contraction of vascular smooth muscle induced by phorbol 12,13 dibutyrate in human and rat pulmonary arteries. Br. J. Pharmacol. 104: 639-644, 1991.
36. 2+] in permeabilized HSY cells. J. Biol. Chem. 271: 30904-30908, 1996.
37. 2(+)-ATPase. Proc. Natl. Acad. Sci. USA 87: 2466-2470, 1990.
38. Thomas, A. P., G. S. Bird, G. Hajnoczky, L. D. Robb-Gaspers, and J. W. Putney, Jr. Spatial and temporal aspects of cellular calcium signaling. FASEB J. 10: 1505-1517, 1996.
39. 2+ concentration. Philos. Trans. R. Soc. Lond. B Biol. Sci. 265: 57-71, 1973.
40. Van Renterghem, C., and M. Lazdunski. Endothelin and vasopressin activate low conductance chloride channels in aortic smooth muscle cells. Pflügers Arch. 425: 156-163, 1993.
41. Van Renterghem, C., P. Vigne, J. Barhanin, A. Schmid-Alliana, C. Frelin, and M. Lazdunski. Molecular mechanism of action of the vasoconstrictor peptide endothelin. Biochem. Biophys. Res. Commun. 157: 977-985, 1988.
42. Williams, D. L., K. L. Jones, D. J. Pettibone, E. V. Lis, and B. V. Clineschmidt. Sarafotoxin S6c: an agonist which distinguishes between endothelin receptor subtypes. Biochem. Biophys. Res. Commun. 175: 556-561, 1991.
43. Yoshida, M., A. Suzuki, and T. Itoh. Mechanisms of vasoconstriction induced by endothelin-1 in smooth muscle of rabbit mesenteric artery. J. Physiol. (Lond.) 477: 253-265, 1994.
44. Yuan, X. J. Role of calcium-activated chloride current in regulating pulmonary vasomotor tone. Am. J. Physiol. 272 (Lung Cell. Mol. Physiol. 16): L959-L968, 1997.
45. Zamora, M. A., E. C. Dempsey, S. J. Walchak, and T. J. Stelzner. BQ123, an ETA receptor antagonist, inhibits endothelin-1-mediated proliferation of human pulmonary artery smooth muscle cells. Am. J. Respir. Cell Mol. Biol. 9: 429-433, 1993.
46. 2+ channel/ryanodine receptor: modulation by endogenous effectors, drugs and disease states. Pharmacol. Rev. 49: 1-51, 1997.